FDA Panel Wants Suicide Warning on Antidepressants
Wednesday September 15, 2004
A U.S. Food and Drug Administration commission voted yesterday to recommend that the FDA require makers of SSRI antidepressants to add a "black box" label warning that the drugs can be linked to suicidal thoughts and behavior in children and adolescents.
Which medications are likely to get the warning?
Which medications are likely to get the warning?
Comments
No comments yet. Leave a Comment